Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Opko Health Inc (NQ: OPK ) 1.525 +0.015 (+0.99%) Streaming Delayed Price Updated: 3:52 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Opko Health Inc < Previous 1 2 3 4 5 6 Next > Mid-Afternoon Market Update: Nasdaq Down 250 Points; OPKO Health Shares Plunge January 24, 2022 Toward the end of trading Monday, the Dow traded down 1.84% to 33,636.46 while the NASDAQ fell 1.83% to 13,517.61. The S&P also fell, dropping, 1.98% to 4,310.71. The U.S. has... Via Benzinga Mid-Day Market Update: Dow Dips 1000 Points; Exterran Shares Jump January 24, 2022 Midway through trading Monday, the Dow traded down 3.09% to 33,205.52 while the NASDAQ fell 4.56% to 13,141.60. The S&P also fell, dropping, 3.82% to 4,230.05. The U.S. has... Via Benzinga Pfizer Dives After FDA Rejects Its OPKO-Partnered Rare Disease Treatment January 24, 2022 Pfizer stock tumbled after the FDA rejected an OPKO-partnered drug. Via Investor's Business Daily 12 Health Care Stocks Moving In Monday's Pre-Market Session January 24, 2022 Gainers SAB Biotherapeutics (NASDAQ:SABS) stock moved upwards by 15.0% to $6.3 during Monday's pre-market session. The market value of their outstanding shares is at $... Via Benzinga Earnings Scheduled For October 28, 2021 October 28, 2021 Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •... Via Benzinga 54 Stocks Moving In Monday's Mid-Day Session January 24, 2022 Gainers Exterran Corporation (NYSE: EXTN) shares jumped 52.4% to $4.5720 after the company said it would merge with Enerflex to create a premier integrated global provider of... Via Benzinga Benzinga Pro's Top 5 Stocks To Watch For Monday, Jan. 24, 2022: UL, SNAP, OPK, M, IBM January 24, 2022 Today's 5 Stock Ideas: Unilever (UL) - Shares rose following a media report that hedge fund Trian Partners has built a stake in the company. Snap (SNAP) - Wedbush... Via Benzinga 28 Stocks Moving in Monday's Pre-Market Session January 24, 2022 Gainers BT Brands, Inc. (NASDAQ: BTBD) shares rose 158% to $6.37 in pre-market trading after declining around 12% on Friday. Kohl's Corporation (NYSE: KSS) rose 28.4% to $60... Via Benzinga A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge January 24, 2022 Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled 450 points in the previous session. Investors are awaiting earnings results... Via Benzinga Pfizer - OPKO Health's Growth Hormone Deficiency Candidate Receives FDA Response Letter January 24, 2022 The FDA has issued a Complete Response Letter (CRL) to Pfizer Inc (NYSE: PFE) and OPKO Health Inc's (NASDAQ: OPK) somatrogon. Somatrogon... Via Benzinga Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency January 21, 2022 From Pfizer Inc. Via Business Wire 12 Health Care Stocks Moving In Tuesday's Intraday Session January 18, 2022 Gainers Brickell Biotech (NASDAQ:BBI) shares moved upwards by 71.1% to $0.36 during Tuesday's regular session. Brickell Biotech's stock is trading at a volume of... Via Benzinga Sema4 Strengthens AI-Driven Genomic, Clinical Data Platform With $623M GeneDx Acquisition January 18, 2022 Sema4 Holdings Corp (NASDAQ: SMFR) has agreed to acquire OPKO Health Inc's (NASDAQ: OPK) wholly-owned subsidiary, GeneDx Inc, for approximately $623... Via Benzinga OPKO Health to Participate in the 40th Annual J.P. Morgan Healthcare Conference January 05, 2022 From OPKO Health, Inc. Via Business Wire Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates December 31, 2021 Regulatory decisions by the U.S. Food and Drug Administration in December turned out to be mostly positive. Among the treatment options that were greenlighted in the month were... Via Benzinga Opko Health Posts Data From COVID-19 Trial With Its Kidney Disease Treatment December 23, 2021 OPKO Health Inc (NASDAQ: OPK) has announced preliminary topline results from its Phase 2 trial with Rayaldee to treat mild-to-moderate COVID-19. This study... Via Benzinga Bulls Find Silver Lining Into the Close December 20, 2021 While it isn't exactly a ringing endorsement that the market is heading higher, it is an indication that the Grinch hasn't entirely spoiled the fun. Via Talk Markets 63 Biggest Movers From Friday December 20, 2021 Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session December 17, 2021 Gainers Genfit (NASDAQ:GN... Via Benzinga 28 Stocks Moving In Friday's Mid-Day Session December 17, 2021 Gainers Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor. X4 Pharmaceuticals, Inc... Via Benzinga OPKO Health Q3 Earnings Ahead Of Expectations October 29, 2021 OPKO Health Inc (NASDAQ: OPK) reported Q3 revenues were down 10% Y/Y to $385.8 million, beating the consensus of $302.27 million. Revenue from diagnostic services... Via Benzinga Opko Health (OPK) Q3 2021 Earnings Call Transcript October 29, 2021 OPK earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial 12 Health Care Stocks Moving In Thursday's After-Market Session October 28, 2021 Gainers Bellerophon Therapeutics (NASDAQ: Via Benzinga This Growth Hormone Drug Could Be a Boost For Pfizer October 05, 2021 Pfizer and OPKO Health's human growth hormone drug, somatrogon, could be approved by the U.S. Food and Drug Administration next January. Via The Motley Fool Exposures Product Safety Pfizer's Growth Hormone Candidate FDA Review Pushed By 3 Months September 27, 2021 Pfizer Inc's (NYSE: PFE) effort to defend its growth hormone franchise against a new, more convenient competitor has hit a snag. The FDA has pushed back... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Friday's After-Market Session September 24, 2021 Gainers eFFECTOR Therapeutics (NASDAQ: Via Benzinga The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical August 31, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... Via Benzinga Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program August 26, 2021 From Rite Aid Corporation Via Business Wire Why Opko Health Shares Shriveled by Nearly 8% on Friday July 30, 2021 The coronavirus stock didn't impress with its Q2 results. Via The Motley Fool Exposures COVID-19 Opko Health (OPK) Q2 2021 Earnings Call Transcript July 30, 2021 OPK earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
